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Abstract Resistance exercise disturbs skeletal muscle
homeostasis leading to activation of catabolic and ana-
bolic processes within the muscle cell. A current chal-
lenge of exercise biology is to describe the molecular
mechanisms of regulation by which contractile activity
stimulates net protein breakdown during exercise and
net protein synthesis during recovery. Muscle growth is
optimized by combining exercise and appropriate
nutritional strategies, such as amino acid (AA) and
carbohydrate ingestion. The effects are integrated at the
level of one central regulatory protein, mTOR (mam-
malian target of rapamycin). mTOR is a complex pro-
tein integrating signals of the energetic status of the cell
and environmental stimuli to control protein synthesis,
protein breakdown and therefore cell growth. mTOR is
known to be activated by insulin, and the mechanisms
involved are well documented. The ways by which
exercise and AA lead to mTOR activation remain par-
tially unclear. Exercise and AA use different signalling
pathways upstream of mTOR. Exercise seems to recruit
partially the same pathway as insulin, whereas AA could
act more directly on mTOR. During resistance exercise,
the activity of mTOR could be acutely blunted by AMP-
activated protein kinase (AMPK), thus inhibiting pro-
tein synthesis and enhancing AA availability for energy
metabolism. During recovery, the inhibition of mTOR
by AMPK is suppressed, and its activation is maximized
by the presence of AA. There appears to be a require-
ment for a minimal concentration of plasma insulin to
stimulate muscle protein synthesis in response to resis-
tance exercise and AA ingestion.
Keywords Protein synthesis Æ p70 ribosomal S6
kinase Æ eukaryotic initiation factor 4E-binding
protein Æ protein kinase B/Akt Æ AMP-activated
protein kinase
Introduction
Resistance exercise leads to changes in protein turnover
in skeletal muscle up to 48 h after the completion of a
training session (Phillips et al. 1997). At rest in the fasted
state, the net protein balance is negative, because protein
breakdown largely exceeds protein synthesis. Following
exercise in the fasted state, protein synthesis as well as
protein breakdown are enhanced, although the latter is
less so, resulting in a less negative net balance (Biolo
et al. 1995; Phillips et al. 1997; Tipton and Wolfe 1998).
Most athletes involved in resistance training are looking
for increased muscle mass. Ingesting a mixture con-
taining carbohydrate (CHO) and amino acids (AA),
preferentially before (Tipton et al. 2001) or immediately
after (Biolo et al. 1997) completion of the training ses-
sion, counteracts the catabolic state by increasing AA
transport and availability into the muscles (Biolo et al.
1995). In this situation, protein synthesis (Louis et al.
2003; Tipton and Wolfe 1998), but not protein break-
down (Biolo et al. 1995; Phillips et al. 1997), is enhanced,
and the net protein balance becomes positive. The effect
of AA is enhanced by an elevated insulin concentration
subsequent to CHO supplementation (Rasmussen et al.
2000). Nutritional strategies centred around the inges-
tion of AA are essential to maximize the effect of resis-
tance training and therefore to accumulate muscle mass
(Wolfe 2000).
The mechanisms of activation of protein synthesis by
AA and exercise are somewhat different. Both use dis-
tinct signalling pathways converging at the level of one
central protein involved in cell growth called mTOR
(mammalian target of rapamycin). mTOR is a 289 kDa
serine/threonine kinase composed of 2,459 AA. This
large protein has also been called FRAP [FK506-bind-
ing protein 12 (FKBP-12) and rapamycin-associated
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protein], RAFT1 (rapamycin and FKBP-12 target-1),
RAPT1 (rapamycin target-1) or SEP (sirolimus effector
protein). mTOR stimulates protein synthesis mainly via
three key regulatory proteins: p70s6k (p70 ribosomal S6
kinase), 4E-BP1 (eukaryotic initiation factor 4E-binding
protein 1) (Brunn et al. 1997; Burnett et al. 1998) and
eIF4G (eukaryotic initiation factor 4G) (Raught et al.
2001). The purpose of this review is to describe the roles
and the mechanisms of regulation of the mTOR-medi-
ated signalling by AA and exercise. The first part will
describe the roles and the regulation mechanisms of
mTOR and its downstream effectors. Next, the role of
AA in mTOR activation will be discussed. Finally, the
effect of exercise and AA on mTOR signalling will be
analyzed. Optimal stimulation of muscle growth is
highly dependent on the fine-tuned integration of these
two pathways.
Roles of mTOR
Some authors present mTOR as an energetic sensor,
although mTOR has a relatively high Km for ATP
(1 mM) (Dennis et al. 2001). Therefore, a large drop in
ATP is needed to induce a substantial effect on mTOR
activity, as opposed to AMP-activated protein kinase
(AMPK) which is a more sensitive energetic sensor to
detect small variations in AMP concentration. A major
role of mTOR is to integrate environmental stimuli
(nutrient and growth factor levels, mitochondrial signals
and exercise) in order to control cellular growth (Fig. 1)
(for reviews, see Proud 2002; Raught et al. 2001). Pro-
tein synthesis is one of the most highly regulated pro-
cesses. Cell growth is well organized and occurs at
specific moments and in well-defined cellular compart-
ments. To develop, the cell must integrate mitogenic and
nutritional signals. One of the most powerful anabolic
signals is insulin, which acts, among others, through
mTOR-mediated signalling. Once bound to its receptor,
insulin activates the intrinsic kinase activity of the
receptor leading to its autophosphorylation (Kasuga
et al. 1982) and phosphorylation of several substrates,
including members of the insulin receptor substrate
(IRS) family (White et al. 1985). Phosphorylation of
IRS-1 recruits another signalling molecule, the phos-
phatidylinositol 3-kinase (PI3K) (Backer et al. 1993).
One downstream target of PI3K is the serine/threonine
protein kinase B (PKB) which activates mTOR directly
and indirectly (see TSC1/TSC2 and Rheb) and its
downstream effectors involved in the control of protein
translation, p70s6k, 4E-BP1 and eIF4G (Fig. 2).
mTOR could control other processes such as auto-
phagy (Blommaart et al. 1995; Noda and Ohsumi 1998),
cell proliferation (Coolican et al. 1997; Gao et al. 2004;
Shah et al. 2001) and cytoskeletal organization (Berven
and Crouch 2000; Berven et al. 2004; Qian et al. 2004)
(Fig. 1). Although the main focus of this review is on
protein translation, it should be noted that mTOR also
regulates gene transcription (Mayer et al. 2004), as
demonstrated by studies using rapamycin, an inhibitor
of mTOR.
Fig. 1 Roles of mTOR (mammalian target of rapamycin). mTOR
signalling is activated in the presence of insulin, growth factors,
amino acids and during exercise, whereas it is repressed by
rapamycin. When activated, mTOR inhibits autophagy, and
stimulates transcription, translation of mRNAs coding for com-
ponents of the translation machinery, ribosome biosynthesis, cell
proliferation and cytoskeletal organization to favour cell growth
Fig. 2 Inhibition of mTOR by TSC1/TSC2 (tuberous sclerosis
complex 1/2). TSC2 is a GTPase-activating protein for the small
G protein Rheb (Ras homologue enriched in brain). The GAP
domain of TSC2 increases the hydrolysis of the GTP form of Rheb,
inhibiting the signal to propagate through mTOR. Rheb, under
active form (Rheb–GTP), could facilitate the transport of amino
acids into the cell, which in turn could activate mTOR. IRS-1
Insulin receptor substrate 1, PI3K, phosphatidylinositol 3-kinase,
PKB protein kinase B, mTORK mammalian target of rapamycin
kinase, p70s6k p70 ribosomal S6 kinase, 4E-BP1 eukaryotic
initiation factor 4E-binding protein 1
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Regulation of mTOR and its downstream targets
In the N-terminal region, mTOR possesses 16 HEAT
domains which allow the binding of various regulatory
proteins. The activity of mTOR is also influenced by
changes in its phosphorylation state. Up to now, three
phosphorylation sites have been discovered: Ser 2,481,
an autophosphorylation site, Ser 2,448 and Thr 2,446,
the roles of which are described in later sections. Once
phosphorylated, mTOR can in turn phosphorylate
downstream targets. The major proteins regulated by
mTOR and playing a role in translation are 4E-BP1,
eIF4G, and p70s6k (Raught et al. 2001). The mechanism
by which mTOR activates its effectors is not fully elu-
cidated. mTOR could stimulate 4E-BP1, eIF4G, and
p70s6k either directly by phosphorylation (Raught et al.
2001), indirectly by activating another protein kinase
(Raught et al. 2001), or by inhibiting a phosphatase (e.g.
protein phosphatase 2A, PP2A) (Li et al. 2004).
4E-BP1 is an inhibitor of the initiation translation
factor eIF4E (eukaryotic initiation factor 4E). When 4E-
BP1 is phosphorylated, eIF4E is released and can form
the eIF4F complex together with eIF4G, which is also
under the control of mTOR (Raught et al. 2001), and
eIF4A. The assembly of this complex is necessary for
initiation to continue. 4E-BP1 possesses many phos-
phorylation sites. The phosphorylation of Ser 65 and
Thr 70 (and to a lesser extent Thr 37 and 46) is blocked
in the presence of rapamycin suggesting an essential role
of mTOR in the regulation of 4E-BP1 (Proud 2002).
p70s6k is a member of the S6K family. The S6Ks are a
product of two genes, S6K1 and S6K2, p70s6k being
encoded by the first one. Up to now 12 sites of phos-
phorylation have been described for p70s6k (Shah et al.
2000). The Thr 389 is a direct target of mTOR in vitro
(Dennis et al. 1999). The phosphorylation of Thr 389 by
mTOR allows subsequent phosphorylation of Thr 229
by the phosphoinositide-dependant kinase 1 (PDK1). It
is generally assumed that, when activated, the S6K
proteins phosphorylate the ribosomal S6 protein. The
latter controls the translation of a class of mRNAs
called the 5¢TOP (tract of pyrimidine) mRNAs, al-
though, for some authors, this process does not require
S6K or S6 phosphorylation (Stolovich et al. 2002). The
TOP mRNAs encode for ribosomal proteins and pro-
teins implicated in translation, such as eEF2 (eukaryotic
elongation factor 2) (Proud 2002). eEF2 mediates the
translocation during the elongation phase. It binds the
guanidic nucleotides and is active when bound to GTP.
Furthermore, the activity of eEF2 can be inhibited by
phosphorylation on Thr 56 via its kinase eEF2K. p70s6k
can inhibit eEF2K by phosphorylation, thus increasing
the activity of eEF2 (Browne et al. 2004). In summary,
p70s6k is involved in the expression as well as in the
activity of eEF2. Another potent target of the S6K
family is the phosphoprotein eIF4B which stimulates the
activity of eIF4A (see previous paragraph) (Raught et al.
2001).
Rapamycin-FKBP12
Rapamycin regulates the protein kinase activity ofmTOR.
Once bound to its intracellular receptor FKBP12 (also
called FK506-binding protein), rapamycin specifically
interacts with mTOR and inhibits the signalling down-
stream of mTOR in vitro. However, the concentrations of
rapamycin required to inhibit the activity of mTOR in
vitro aremuch higher than in vivo (500 nMvs 25 nM). It is
likely that rapamycin does not directly modulate the
activity of mTOR, but when bound to it, rapamycin could
activate a phosphatase which could act on the effectors
downstream of mTOR (Raught et al. 2001).
Raptor, rictor and GbL
The activity of mTOR is also controlled by several
binding partners such as the regulatory associated pro-
tein to mTOR (raptor), the rapamycin-insensitive com-
panion of mTOR (rictor) and GbL (also called mLST8).
Raptor and rictor independently associate with mTOR
and GbL and define two distinct mTOR complexes
(Sarbassov et al. 2004). Raptor seems to serve as an
mTOR scaffolding protein whose association with
mTOR is required for an efficient phosphorylation of
4E-BP1 and p70s6k (Nojima et al. 2003). Binding of
raptor to mTOR could influence the sensitivity of
mTOR to rapamycin and AA (Kim et al. 2002). How-
ever, further investigations are needed to clarify the
interaction between mTOR and raptor, and how raptor
alters the kinase activity of mTOR.
Raptor not only binds to mTOR but also to p70s6k
and 4E-BP1 through their respective TOS (conserved
TOR signalling) motifs. The TOS motif is a short con-
served sequence required for AA- and mTOR-dependent
activation of the downstream effectors of mTOR. A
mutation in the TOS motif of p70s6k and 4E-BP1 that
prevents both AA- and mTOR-regulation also abolishes
their binding to raptor.
Unlike raptor, the recently discovered rictor is insen-
sitive to rapamycin and does not regulate p70s6k. Rather,
the rictor–mTOR complex modulates the organization of
the actin cytoskeleton and cell morphology. PKCa (pro-
tein kinase Ca) is a mediator of this function, but it is
likely that other effectors are involved in controlling the
actin cytoskeleton (Sarbassov et al. 2004).
TSC1/TSC2 and Rheb
mTOR can be directly activated by PKB phosphory-
lating Ser 2,448 (Nave et al. 1999). Recently, an addi-
tional control mechanism of mTOR via PKB has been
suggested, implicating the proteins TSC1 and TSC2
(tuberous sclerosis complex 1 and 2). TSC1 and TSC2,
also called hamartin and tuberin respectively, form a
complex and repress mTOR. This inhibition on mTOR
can be reversed when TSC2 is phosphorylated by PKB,
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which induces the dissociation of the complex (Fig. 2).
PKB phosphorylates TSC2 on Ser 939, Ser 1,086, Ser
1,088 and Thr 1,422. According to some authors (Liu
et al. 2002; Nellist et al. 2003), the phosphorylation of
these sites by PKB is responsible for the binding of the
14-3-3 protein to TSC2. The 14-3-3 protein family has
many roles in cell metabolism (Siles-Lucas and Gottstein
2003), amongst which the modulation of the TSC2
activity. According to others (Li et al. 2002; Shumway
et al. 2003), it is the phosphorylation of TSC2 on Ser
1,210 by the p38 mitogen-activated protein-kinase-acti-
vated protein kinase 2 (MAPKAPK2) that would be
essential for the binding of the 14-3-3 protein.
TSC2 is a GTPase-activating protein (GAP) for the
small G protein Rheb (Ras homologue enriched in
brain). When Rheb is bound to GTP, mTOR is activated
(Fig. 2). The GAP domain of TSC2 increases the
hydrolysis of the GTP form of Rheb preventing the signal
propagating through mTOR. Up to now no guanine-
nucleotide exchange factor (GEF) to counter the GAP
activity of TSC2 has been discovered. It has been pro-
posed that Rheb might not require a GEF for its acti-
vation because Rheb exists in a highly GTP-bound state
and has low intrinsic GTPase activity (Im et al. 2002).
Unlike TSC2, TSC1 has no GAP activity. Its role is rather
to stabilize TSC2 and thereby to prevent TSC2 from
ubiquitinization and degradation (Li et al. 2004).
Several mechanisms have been proposed to explain
how Rheb could activate mTOR (Fig. 2). First, Rheb
could be a component of the complex formed by mTOR
and other proteins, thus regulating mTOR directly or via
these binding proteins. As up to now no direct associa-
tion between Rheb and mTOR has been demonstrated,
it is likely that Rheb activates a binding protein of
mTOR rather than mTOR directly. Secondly, mTOR
could play a role in the detection of the intracellular AA
level. It is then possible that Rheb activates mTOR
indirectly by facilitating the transport of AA into the cell
(Li et al. 2004). Thirdly, Rheb could activate an un-
known kinase that phosphorylates mTOR. In HEK293
cells, overexpression of Rheb has been shown to increase
the phosphorylation of mTOR on Ser 2,448 (Inoki et al.
2003a). This activation of mTOR by overexpressing
Rheb can even occur in the absence of growth factors or
AA (Inoki et al. 2003a; Tee et al. 2003). Conversely,
overexpression of TSC1 and TSC2 blocks the ability of
AA (Gao et al. 2002; Inoki et al. 2002; Tee et al. 2002)
and Rheb (Inoki et al. 2003a; Tee et al. 2003) to activate
mTOR. In summary, several hypotheses have been
proposed to explain the mechanism of activation of
mTOR by Rheb, but the effector(s) of Rheb that regu-
late(s) mTOR directly or indirectly remain(s) unknown.
AMP-activated protein kinase
AMPK is a heterotrimeric complex including one cata-
lytic subunit, a, and two non-catalytic subunits, b and c.
AMPK is activated when AMP increases and when the
catalytic subunit a is phosphorylated by one or several
AMPK kinases on Thr 172, located in the ‘‘T loop’’ of the
catalytic domain. Once activated, AMPK phosphorylates
many substrates, the purpose of which is to maintain the
intracellular ATP level.When theATP concentration falls,
AMPK prevents the consumption of ATP by inhibiting
key enzymes of anabolic pathways. AMPK also increases
ATP synthesis by stimulating for example the rate of
fatty acid oxidation and the uptake of glucose by the cell
(Yonezawa 2003). It has been reported that, when acti-
vated, AMPK could either phosphorylate TSC2 on Thr
1,227 and Ser 1,345 thereby enhancing its activity (Inoki
et al. 2003b), or phosphorylate mTOR on Thr 2,446
resulting in its inhibition (Cheng et al. 2004). However, the
latter results need to be confirmed, and it ismore likely that
AMPK does not inhibit mTOR directly but through the
phosphorylation of TSC2 (Inoki et al. 2003b).
mTOR and AA
Protein synthesis is an energy consuming process. Dur-
ing translation elongation, four ATP equivalents are
used for each AA added to the nascent peptide chain
(Browne and Proud 2002). Energy consumption by
protein synthesis is small when compared to muscle
contraction, but it can contribute significantly to the
energy consumption of a resting muscle. If AA are
lacking, the cell should conserve its energy and avoid
expensive anabolic processes. On the other hand, if AA
availability is sufficient, the cell has to increase the rate
of protein translation to ensure cell growth. There is
evidence for AA playing a role in the translational reg-
ulation of protein synthesis. In skeletal muscle of rats in
the fasted state, the mTOR-mediated signalling is re-
duced compared with the fed state. In a study with
fasted animals, 4E-BP1 was highly present in hypo-
phosphorylated forms (Yoshizawa et al. 1997, 1998),
sequestering eIF4E and inhibiting the formation of the
initiation complex eIF4F. In contrast, when the rats
received a protein-containing meal, 4E-BP1 became
hyperphosphorylated and promoted the formation of
the eIF4F complex. This positive effect on muscle pro-
tein synthesis can also be observed with oral leucine
administration alone (Anthony et al. 2000). In addition
to promoting eIF4F assembly, either feeding a complete
meal or oral administration of leucine promotes phos-
phorylation of p70s6k (Anthony et al. 2000).
Types of AA
AA are known to stimulate protein synthesis, but the
mechanisms of activation differ according to the AA
studied (Meijer and Dubbelhuis 2004). AA can be clas-
sified into two major categories. AA in the first category
induce cell swelling because of an increase in the intra-
cellular osmolarity following Na+-dependent AA trans-
port across the membrane, and because some products of
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their metabolism accumulate in the cell (e.g. glutamate).
Cell swelling per se induces protein, glycogen and lipid
synthesis. The second category of AA is represented by
leucine which does not induce cell swelling and which
essentially regulates protein metabolism by stimulating
protein synthesis and by inhibiting autophagy.
A group of AA, the branched chain AA (BCAA),
including leucine, valine and isoleucine, seem to be
particularly effective anabolic agents, especially leucine
which has the most potent effect on the phosphorylation
state of p70s6 k in the skeletal muscle (Anthony et al.
2000) and in various cell lines (Patti et al. 1998; Xu et al.
1998). It is possible that AA activate mTOR through a
permissive action of insulin (Jefferson and Kimball
2003). Even low levels of insulin could maintain a min-
imal activation level of the PI3K/PKB pathway by
stimulating the PI3K class 1 and subsequently allowing
AA to activate the downstream targets of mTOR in
many different cell types (hepatocytes, adipocytes,
myocytes and pancreatic cells).
Mechanisms involved in AA regulation
The way by which AA stimulate mTOR is not fully
understood, but they do not act like growth factors or
insulin which modulate PI3K and its downstream
effector PKB (see Roles of mTOR). Indeed, activation of
mTOR via AA does not require activation of PKB
(Jefferson and Kimball 2003). Several hypotheses have
been proposed to explain the activation of mTOR by
AA (Fig. 3). AA could stimulate a protein kinase (other
than PKB) acting on mTOR, or they could inhibit a
protein phosphatase, such as PP2A. This protein phos-
phatase could act on mTOR or on the downstream
proteins. AA could also interact with proteins associated
with mTOR (raptor) or acting on mTOR (TSC1/TSC2,
AMPK) (Meijer and Dubbelhuis 2004). Some authors
have hypothesized that AA increase the phosphorylation
on Ser 2,448 by facilitating the dissociation of the
complex TSC1/TSC2 from mTOR and allowing PKB to
access on Ser 2,448 (Kanazawa et al. 2004). Finally, a
direct activation of mTOR by AA could be possible but
remains controversial. In conclusion, the molecular
nature of AA sensing and the regulation of TSC1/TSC2,
Rheb and mTOR by AA remain poorly understood.
Although the mTOR pathway plays a major role in
the regulation of protein synthesis, it should be men-
tioned that AA can stimulate cell growth independently
of mTOR, and that the involvement of mTOR varies
greatly among cell lines. In L6 myoblasts, eIF2B
(eukaryotic initiation factor 2B), which is not under the
control of mTOR, appears to be more involved in the
activation of protein synthesis by AA than eIF4E
(Kimball et al. 1998). In isolated rat ventricular myo-
cytes, protein synthesis is acutely activated by insulin
(Wang et al. 2000) and this effect is blunted by only
around 50% by rapamycin. In skeletal muscle, the
activation of protein synthesis by leucine is only partially
inhibited by rapamycin (Anthony et al. 2000). Thus it is
likely that leucine stimulates protein synthesis via an
mTOR-dependent and an mTOR-independent path-
way(s) (Proud 2002).
Autophagy
The presence of AA not only stimulates protein syn-
thesis but also represses autophagy. Autophagy is the
only proteolytic system that can be regulated by the
nutritional state. When the nutritional state is low,
eukaryotic cells degrade their proteins to scavenge AA.
The first step of this autophagy consists in the seques-
tration of a portion of the cytoplasm inside a double
membrane structure called autophagosome. This struc-
ture fuses then with lysosomal membranes where the
cytoplasmic components can be degraded (Raught et al.
2001). AA and insulin are the main physiological regu-
lators of autophagy in mammals, but it seems that they
use different ways to control it. The pathway used by
insulin to regulate autophagy is partially the same as for
protein synthesis. On the contrary, it seems that the
signalling used by AA in autophagy is independent of
protein synthesis and that AA have their own signal
transduction mechanisms (Kanazawa et al. 2004). In a
perfused liver, autophagy is controlled by the extracel-
lular concentrations of phenylalanine and leucine. Leu8-
MAP, an analogue of leucine that cannot be transported
inside the cell, mimics the effect of leucine. It can be
speculated that AA have their own recognition site on
the surface of the membrane and their own signal
Fig. 3 Hypotheses for activation of mTOR by amino acids (AA)
(see text for details). (1) AA could stimulate a protein kinase
(mTORK mammalian target of rapamycin kinase) acting on
mTOR. (2) AA could inhibit a protein phosphatase such as
PP2A (protein phosphatase 2A) which could act on mTOR or on
the downstream proteins of mTOR. (3) AA could interact with
proteins associated with mTOR (raptor regulatory associated
protein to mTOR) or acting on mTOR (TSC1/TSC2, AMPK
AMP-activated protein kinase). (4) AA could activate mTOR
directly
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transduction mechanisms up to the formation site of the
autophagosome in the cell (Kanazawa et al. 2004).
mTOR could be a central component of the signal
transduction of autophagy (Fig. 1), whereas down-
stream effectors of mTOR are not well known. In yeast,
autophagy induced by fasting is controlled by TOR via a
complex Apg1–Apg13, which plays a role in the initial
formation of the phagosome (Kamada et al. 2000). In
isolated hepatocytes, inhibition of autophagy by AA
occurs via the phosphorylation of the ribosomal protein
S6 (Blommaart et al. 1995). As described above, phos-
phorylation of S6 is activated by p70s6k, a direct target
of mTOR. However some studies do not support the
hypothesis of mTOR involvement in autophagy. In
mouse C2C12 myotubes, mTOR signalling pathway was
not involved in the regulation of autophagy by leucine
(Mordier et al. 2000). Furthermore rapamycin had no
effect on the suppression of autophagic proteolysis by
AA in isolated hepatocytes (Kanazawa et al. 2004). The
discrepancy between these studies and the study of
Blommaart et al. (1995) could be explained by meth-
odological considerations which are beyond the scope of
this review. Clearly more research is warranted to clarify
if and how mTOR regulates autophagy in skeletal
muscle.
mTOR and exercise
Acute resistance exercise is known to increase skeletal
muscle protein synthesis during the recovery phase. Both
concentric and eccentric contractions seem to be effec-
tive in promoting protein synthesis (Phillips et al. 1997,
1999; Wong and Booth 1990). Two major pathways
leading to protein synthesis have been proposed to
induce this increase: the PI3K/PKB/mTOR and the
calcineurin/NFAT (nuclear factor of activated T cells)
pathways. The PI3K/PKB/mTOR pathway could be
involved mainly in skeletal muscle growth (Pallafacchina
et al. 2002), whereas the calcineurin/NFAT pathway,
and to a lesser extent the Ras/MAPK (mitogen-activated
protein kinase) pathway, control muscle fibre type
(Fig. 4) (Serrano et al. 2001). Indeed, inhibitors of cal-
cineurin, cyclosporin A and FK506, do not blunt
muscle hypertrophy, as shown by increases in plantaris
muscle mass and fibre size of rats after overload (Bodine
et al. 2001). In contrast, specific inhibition of mTOR
with rapamycin leads to a 95% blockade of hypertro-
phy, indicating that mTOR and its downstream targets,
p70s6k and 4E-BP1, are crucial regulators of muscle
hypertrophy (Bodine et al. 2001).
Protein kinase B
No information is available to date on the activation of
PI3K following skeletal muscle overload. However, a
series of studies have demonstrated upregulation of PKB
activity. PKB phosphorylation on Ser 473 was almost
tripled immediately after high-frequency electrical stim-
ulation (Nader and Esser 2001), and was higher in rat
plantaris muscle after a few days overloading compared
to control conditions (Bodine et al. 2001). PKB activity
increased 2.5-fold from day 3 to day 10 in regenerating
innervated soleus muscle after injury. In the same study,
overexpression of active PKB increased fibre size in
regenerating soleus and in adult extensor digitorum
longus (EDL) and soleus muscles (Pallafacchina et al.
2002).
Some results suggest that PKB phosphorylation is
fibre type specific. Indeed, contraction- or stretch-in-
duced activation of PKB was only observed in isolated
fast-twitch EDL but not in isolated slow-twitch soleus
(Sakamoto et al. 2003, 2004). These data provide evi-
dence that the different contractile and/or metabolic
properties of slow or fast fibres confer distinct signalling
properties to mixed skeletal muscles. Because no acti-
vation of PKB by exercise has been observed in isolated
soleus muscle but it occurs well in vivo, it is likely that
systemic factors and/or oxidative stress mediate the
activation of PKB by exercise (Cooper et al. 2002; Shaw
et al. 1998).
Fig. 4 AA and exercise
signalling. AA stimulate skeletal
muscle growth by activating
mTOR and its downstream
effectors (for details see Fig. 3),
whereas exercise acts upstream
of mTOR via PKB to promote
hypertrophy. Exercise also
activates the calcineurin/NFAT
(nuclear factor of activated
T cells) and Ras/MAPK
(mitogen-activated protein
kinase) pathways leading to
muscle fibre type adaptation.
IGF Insulin-like growth factor,
Shc Src-homology and collagen
homology, GSK3 glycogen
synthase kinase 3, eIF2B
eukaryotic initiation factor 2B
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Mammalian target of rapamycin
In contrast to the above described results, some experi-
ments did not reveal an enhanced activity or phos-
phorylation of PKB after exercise (Brozinick and
Birnbaum 1998; Markuns et al. 1999; Parkington et al.
2003; Sakamoto et al. 2002; Sherwood et al. 1999) or
sciatic nerve stimulation, despite mTOR activation
(Parkington et al. 2003). These observations suggest a
PKB-independent activation of mTOR signalling by
contractile activity. In the study of Parkington et al.
(2003), mTOR phosphorylation on Ser 2,448 increased
in tibialis anterior muscle after 6 h recovery, and in
plantaris immediately after and 6 h after the stimulation.
mTOR was not altered in soleus muscle at either time
point. This implies that similar to PKB, mTOR phos-
phorylation depends on muscle fibre type. Indeed,
mTOR phosphorylation in tibialis anterior is preferen-
tially localized in type IIa fibres, suggesting that this
class of fibres may be more responsive to hypertrophy
(Parkington et al. 2003).
p70 Ribosomal S6 kinase
The first report on the phosphorylation state of p70s6k
after exercise in rats was published a few years ago (Baar
and Esser 1999). The phosphorylation of p70s6k was un-
changed immediately after tibialis anterior and EDL
muscle stimulation, but was tripled 3 h and 6 h post-
exercise. This elevated phosphorylation was maintained
until 36 h of recovery. The changes in p70s6k phosphory-
lation after a single bout of resistance exercise could be a
goodmarker for the long-term increases inmuscle mass. A
later study confirmed that the activity of p70s6k is elevated
between 6 h and 24 h after acute resistance exercise but not
immediately after exercise (Hernandez et al. 2000).
Glycogen synthase kinase 3
Glycogen synthase kinase 3 (GSK3) is another effector
of PKB that can regulate muscle hypertrophy, inde-
pendently of the mTOR-mediated pathway (Bodine
et al. 2001). Although GSK3 is controlled by PKB, other
kinases can modulate its activity, such as MAP kinase-
activated protein kinase-1 (also known as RSK2 or
p90rsk) and p70s6k (Cross et al. 1995; Sutherland et al.
1993). The phosphorylation of GSK3 results in its
inhibition and in activation of eIF2B, which stimulates
global protein synthesis. Indeed, eIF2B activity has been
shown to coincide with increased protein synthesis sev-
eral hours following resistance exercise (Farrell et al.
1999). Moreover, exercise itself could inhibit GSK3,
thus increasing the effect of enhanced protein synthesis
(Fig. 4). Stretch-induced activation of PKB in EDL
muscle of rats was fully prevented by wortmannin, an
inhibitor of PI3K, whereas GSK3 phosphorylation was
only partially reduced (Sakamoto et al. 2003). These
results suggest that exercise also regulates GSK3 by a
PKB-independent pathway. In humans, phosphoryla-
tion and deactivation of GSK3 by exercise is less clear
(Sakamoto et al. 2004; Wojtaszewski et al. 2001).
Time course of activation of the mTOR-mediated
pathway
Some authors have investigated immediate responses of
the mTOR-mediated signalling after resistance exercise in
skeletal muscle of fed rats (Bolster et al. 2003). Their results
revealed that the PKB/mTORpathwaywas induced after a
few minutes following resistance exercise. The phosphor-
ylation state of PKB,mTOR, p70s6k, ribosomal protein S6,
4E-BP1 and the association of eIF4E to eIF4G peaked
between 5 min and 10 min of recovery. These early re-
sponses may serve as a priming event favouring the growth
response by the cell during exercise recovery. It should be
noted that most variables measured in this study showed a
‘‘bell-shaped’’ curve. Thus, the components of the PKB/
mTOR pathway could be phosphorylated in an oscilla-
tory fashion during the beginning of recovery. The sum-
mation of these transient activations could be critical in
inducing muscle hypertrophy with repeated training ses-
sions (Bolster et al. 2003). The oscillatory fashion of acti-
vation of the PKB/mTORpathway after exercisemakes its
study very difficult, and the time points at which the
samples are taken following exercise may lead to opposing
results, as illustrated by the previously cited studies.
Even if the literature is abundant regarding the study
of the PKB/mTOR pathway and exercise, one major
question remains unanswered at this time: what is the
link between contraction and activation of the PKB/
mTOR pathway? Several hypotheses have been pro-
posed to explain the changes in muscle protein synthesis
induced by exercise. In the short term, calcium release (Ji
et al. 2002) and integrin signalling (MacKenna et al.
1998) are important actors in the responses to stretch in
muscle. However, up to now there is no evidence linking
one of these factors, exercise and the activation of PKB/
mTOR signalling. In the long term, insulin-like growth
factors (IGF) and the so-called mechanical growth fac-
tor (Goldspink 1999) could stimulate a late sustained
response leading to muscle hypertrophy (Rennie and
Wackerhage 2003). Indeed, resistance exercise increases
the expression of IGF-I, which is known to be a potent
activator of the PKB/mTOR pathway. However, the
involvement of other, so far unknown, players cannot be
excluded. The summation of both short- and long-term
processes leads to increased muscle protein synthesis and
hypertrophy via activation of the PKB/mTOR pathway
(Rennie and Wackerhage 2003).
mTOR, exercise and AA supplementation
All the previously cited studies were carried out on fed
animals. Because both AA and exercise use the mTOR
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pathway, it is difficult to isolate the effect of exercise on
this pathway. A recent study in humans examined the
effect of exercise on the phosphorylation state of p70s6k
and the S6 ribosomal protein after ingestion of a placebo
or a drink containing BCAA. The phosphorylation of
the S6 ribosomal protein and of p70s6k on Thr 389,
which corresponds to its highest level of phosphoryla-
tion and its highest activity, were only slightly higher 1 h
and 2 h after exercise in the placebo condition, and were
significantly increased at the same time points when the
subject received the drink containing BCAA (Karlsson
et al. 2004). These data suggest that BCAA could exert a
permissive action on the activation of the mTOR-med-
iated pathway by exercise (Karlsson et al. 2004). Fur-
thermore, as previously discussed, there appears to be a
requirement for a minimal concentration of plasma
insulin to stimulate muscle protein synthesis in response
to resistance exercise. However, the concentration of
insulin needed is low, values equivalent to or less than
fasting values are sufficient to induce the effect (Kimball
et al. 2002).
Summary and conclusion
Protein synthesis is enhanced up to 48 h after the com-
pletion of a resistance exercise concomitantly with a lesser
increase in protein breakdown, leading to a positive pro-
tein net balance (Tipton and Wolfe 1998). The opposite
situation occurs during exercise, protein breakdown is
greater than protein synthesis resulting in a negative net
balance. From a biochemical point of view, we are able to
propose the following hypothesis: during acute exercise,
AMPK is activated due to an increase in the AMP/ATP
ratio (Chen et al. 2003; Kemp et al. 1999; Nielsen et al.
2003), and AMPK inhibits mTOR either directly (Cheng
et al. 2004) or via activation of the repressor TSC2 (Inoki
et al. 2003b). mTOR is thus less active in promoting pro-
tein synthesis and preventing autophagy. Increased
breakdown allows for more AA to be available as fuel for
exercise. Once exercise is completed, AMPK activity
quickly returns to basal values. The inhibition onmTOR is
suppressed and the latter becomes able to reduce auto-
phagy and to promote protein synthesis via phosphory-
lation of p70s6k, 4E-BP1 and eIF4G. The role of mTOR
could be to preserve AA from being enrolled in protein
synthesis during exercise through an inhibition by AMPK
and, on the other hand, to favour their utilization and to
promote muscle mass accumulation during recovery.
Many recent investigations focus on exercise and its
influence on translational control of protein synthesis.
Interpretation of the results is complex, since the type,
the frequency and the intensity of muscle contractions,
and also the type of muscle studied and the training status
of the subjects represent factors that may lead to diverse
responses. Different models and experiments may induce
various degrees of muscle damage, AA availability and
hormonal responses, and therefore different adaptations
to exercise. The heterogeneity in the protocols could
\explain some discrepancies in the literature regarding the
exercise signalling. It is, however, very clear that AA
ingestion before or immediately after exercise is necessary
to fully activate protein synthesis signalling in muscle and
therefore to accumulate muscle mass.
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